Voglinorm-GM2 Tablet SR

Product Introduction

Voglinorm-GM2 Tablet SR is a medication primarily prescribed for managing type 2 diabetes mellitus. It belongs to the category of antidiabetic drugs and is formulated to help regulate blood sugar levels effectively. Each tablet contains a combination of two key ingredients: Voglibose and Metformin Hydrochloride (HCl).

Voglibose functions as an alpha-glucosidase inhibitor. It works by delaying the digestion and absorption of carbohydrates in the intestine, thereby reducing the rapid increase in blood glucose levels after meals. Metformin HCl, on the other hand, belongs to the biguanide class of antidiabetic agents. It improves insulin sensitivity, decreases hepatic glucose production, and enhances peripheral glucose uptake, contributing to better overall glycemic control.

The combination of Voglibose and Metformin HCl in Voglinorm-GM2 Tablet SR provides complementary mechanisms of action to effectively manage blood sugar levels in individuals with type 2 diabetes.

Uses of Voglinorm-GM2 Tablet SR

Voglinorm-GM2 Tablet SR is primarily used for the following purposes:

• Type 2 Diabetes Mellitus Management: It is prescribed to individuals diagnosed with type 2 diabetes to help control their blood sugar levels.
• Postprandial Hyperglycemia: Voglinorm-GM2 Tablet SR is particularly effective in controlling the rapid rise in blood glucose levels that occur after meals (postprandial hyperglycemia).
• Combination Therapy: It is often prescribed as a part of combination therapy alongside other antidiabetic medications when monotherapy (single-drug treatment) is insufficient to achieve adequate glycemic control.

Benefits of Voglinorm-GM2 Tablet SR

The benefits of Voglinorm-GM2 Tablet SR include:

• Effective Blood Sugar Control: By inhibiting alpha-glucosidase and improving insulin sensitivity, Voglinorm-GM2 helps in maintaining optimal blood glucose levels throughout the day, including after meals.
• Reduced Risk of Complications: Proper glycemic control with Voglinorm-GM2 Tablet SR may reduce the risk of long-term complications associated with diabetes, such as cardiovascular diseases, neuropathy, and nephropathy.
• Convenient Dosage: The sustained-release formulation of Voglinorm-GM2 Tablet SR allows for once-daily dosing, improving patient compliance and convenience in managing diabetes.

Side Effects of Voglinorm-GM2 Tablet SR

While Voglinorm-GM2 Tablet SR is generally well-tolerated, it may cause some side effects in certain individuals. Common side effects include:

• Gastrointestinal Upset: This may include symptoms such as bloating, flatulence, diarrhea, or abdominal discomfort.
• Hypoglycemia: Although less common compared to some other antidiabetic medications, Voglinorm-GM2 Tablet SR can occasionally cause low blood sugar levels (hypoglycemia), especially when combined with other antidiabetic drugs.
• Lactic Acidosis: A rare but serious side effect associated with metformin use, characterized by symptoms like muscle pain or weakness, dizziness, severe fatigue, and irregular heartbeat. Immediate medical attention is required if these symptoms occur.